CAPTRUST Financial Advisors’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $822K | Buy |
11,021
+6,660
| +153% | +$497K | ﹤0.01% | 1452 |
|
|
2025
Q1 | $277K | Sell |
4,361
-511
| -10% | -$32.5K | ﹤0.01% | 1984 |
|
|
2024
Q4 | $380K | Buy |
4,872
+624
| +15% | +$48.7K | ﹤0.01% | 1767 |
|
|
2024
Q3 | $341K | Buy |
4,248
+982
| +30% | +$78.9K | ﹤0.01% | 1811 |
|
|
2024
Q2 | $270K | Buy |
3,266
+62
| +2% | +$5.13K | ﹤0.01% | 1871 |
|
|
2024
Q1 | $273K | Sell |
3,204
-3,353
| -51% | -$286K | ﹤0.01% | 1827 |
|
|
2023
Q4 | $561K | Sell |
6,557
-4,265
| -39% | -$365K | ﹤0.01% | 1662 |
|
|
2023
Q3 | $969K | Buy |
10,822
+1,865
| +21% | +$167K | ﹤0.01% | 1227 |
|
|
2023
Q2 | $763K | Buy |
+8,957
| New | +$763K | ﹤0.01% | 1375 |
|
|
2022
Q3 | – | Sell |
-2,250
| Closed | -$147K | – | 2910 |
|
|
2022
Q2 | $147K | Sell |
2,250
-85
| -4% | -$5.55K | ﹤0.01% | 1914 |
|
|
2022
Q1 | $148K | Buy |
2,335
+585
| +33% | +$37.1K | ﹤0.01% | 1948 |
|
|
2021
Q4 | $93K | Sell |
1,750
-405
| -19% | -$21.5K | ﹤0.01% | 2216 |
|
|
2021
Q3 | $152K | Buy |
2,155
+105
| +5% | +$7.41K | ﹤0.01% | 1747 |
|
|
2021
Q2 | $137K | Buy |
2,050
+40
| +2% | +$2.67K | ﹤0.01% | 1785 |
|
|
2021
Q1 | $223K | Buy |
2,010
+1,875
| +1,389% | +$208K | ﹤0.01% | 1400 |
|
|
2020
Q4 | $16K | Hold |
135
| – | – | ﹤0.01% | 2357 |
|
|
2020
Q3 | $12K | Buy |
135
+110
| +440% | +$9.78K | ﹤0.01% | 2204 |
|
|
2020
Q2 | $2K | Buy |
+25
| New | +$2K | ﹤0.01% | 2604 |
|
|
2019
Q4 | – | Sell |
-25
| Closed | -$3K | – | 1342 |
|
|
2019
Q3 | $3K | Hold |
25
| – | – | ﹤0.01% | 1736 |
|
|
2019
Q2 | $3K | Buy |
+25
| New | +$3K | ﹤0.01% | 1742 |
|